 | Up a level |
Number of items: 1.
Hoeper, M. M., Ghofrani, H. -A., Benza, R. L., Corris, P. A., Gibbs, S., Klinger, J. R., Langleben, D., McLaughlin, V. V., Peacock, A., Rosenkranz, S., Vonk-Noordegraaf, A., White, J., Kleinjung, F., Meier, C. and Simonneau, G. (2017). Rationale And Design Of The Replace Trial: Riociguat Replacing Phosphodiesterase 5 Inhibitor (pde5i) Therapy Evaluated Against Continued Pde5i Therapy In Patients With Pulmonary Arterial Hypertension (pah). Am. J. Respir. Crit. Care Med., 195. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970